1. Home
  2. FVRR vs BWAY Comparison

FVRR vs BWAY Comparison

Compare FVRR & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fiverr International Ltd. no par value

FVRR

Fiverr International Ltd. no par value

HOLD

Current Price

$11.02

Market Cap

533.3M

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$13.72

Market Cap

450.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FVRR
BWAY
Founded
2010
2003
Country
Israel
Israel
Employees
N/A
N/A
Industry
Business Services
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
533.3M
450.8M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
FVRR
BWAY
Price
$11.02
$13.72
Analyst Decision
Buy
Strong Buy
Analyst Count
9
2
Target Price
$18.43
$13.25
AVG Volume (30 Days)
1.6M
129.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$301.23
Revenue Next Year
$1.83
$24.33
P/E Ratio
$22.05
$81.98
Revenue Growth
N/A
N/A
52 Week Low
$10.15
$7.84
52 Week High
$34.13
$26.63

Technical Indicators

Market Signals
Indicator
FVRR
BWAY
Relative Strength Index (RSI) 37.94 29.78
Support Level $10.25 $11.55
Resistance Level $17.34 $17.20
Average True Range (ATR) 0.53 1.02
MACD 0.20 -0.47
Stochastic Oscillator 44.86 15.00

Price Performance

Historical Comparison
FVRR
BWAY

About FVRR Fiverr International Ltd. no par value

Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Wiring and Translation, and Video and Animation among others.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: